Ignite Creation Date:
2024-05-06 @ 8:13 PM
Last Modification Date:
2024-10-26 @ 3:23 PM
Study NCT ID:
NCT06298552
Status:
RECRUITING
Last Update Posted:
2024-06-18
First Post:
2024-03-01
Brief Title:
A Phase 3 Study to Evaluate the Efficacy and Safety of Efgartigimod IV in Patients with Acetylcholine Receptor Binding Antibody Seronegative Generalized Myasthenia Gravis
Sponsor:
argenx
Organization:
argenx
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-04-16
Start Date Type:
ACTUAL
Primary Completion Date:
2025-07-25
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-07-23
Completion Date Type:
ESTIMATED
First Submit Date:
2024-03-01
First Submit QC Date:
March 1 2024
Study First Post Date:
2024-03-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-26
Last Update Post Date:
2024-06-18
Last Update Post Date Type:
ACTUAL